Skip to main
BLND

Blend Labs (BLND) Stock Forecast & Price Target

Blend Labs (BLND) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 43%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Blend Labs Inc. demonstrates a positive outlook due to its robust pipeline, which has increased by 18% year-over-year and represents over 4% of the 2024 HMDA market share. Recent product innovations, such as the Rapid Refi, are expected to enhance profitability by accelerating the refinancing process and improving the economic value per loan. Furthermore, the company's financial performance is bolstered by a 43% increase in consumer banking suite revenue, indicating effective adaptation and growth in a low-volume mortgage environment.

Bears say

Blend Labs Inc. faces a negative outlook due to a larger than expected decline in mortgage volumes, which negatively impacts its primary revenue-generating segment, the Blend Platform. The company's mortgage economic value per funded loan has decreased from $93 to $88, primarily attributed to its shift towards a partnership model for homeowner insurance and income verification services. Additionally, there are concerns that a more pronounced slowdown in mortgage activity, influenced by anticipated interest rate hikes and post-COVID home buying trends, could hinder Blend's ability to achieve its financial targets.

Blend Labs (BLND) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Blend Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Blend Labs (BLND) Forecast

Analysts have given Blend Labs (BLND) a Buy based on their latest research and market trends.

According to 7 analysts, Blend Labs (BLND) has a Buy consensus rating as of Feb 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Blend Labs (BLND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.